Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancerYanjing Li, Jiaoti Huang, Qingfu Zhang et al.|Science Translational Medicine|2019Cited by 138
Protein Arginine Methyltransferase 5 Promotes pICln-Dependent Androgen Receptor Transcription in Castration-Resistant Prostate CancerElena Beketova, Chang‐Deng Hu, Shuyi Fang et al.|Cancer Research|2020Cited by 40
Characterization of a castrate-resistant prostate cancer xenograft derived from a patient of West African ancestryBrendon M. Patierno, Jennifer A. Freedman, Wen-Chi Foo et al.|Prostate Cancer and Prostatic Diseases|2021Cited by 4
Data from Protein Arginine Methyltransferase 5 Promotes pICln-Dependent Androgen Receptor Transcription in Castration-Resistant Prostate CancerElena Beketova, Chang‐Deng Hu, Shuyi Fang et al.|Unknown|2023Cited by 0